CSN Login
Members Online: 7

Clinical Trial: BKM120 and Irinotecan

Joy1216's picture
Posts: 292
Joined: Mar 2006

A close friend of mine who is not on CSN is starting a phase 1 clinical trial next week at University of Kansas.  Here's the description:  this is a phase 1 trial of the combination of irinotecan and BKM120 in patients with advanced colorectal cancer who have failed on or have become intolerant of at least one line of therapy for advanced colorectal cancer and who are candidates for irinotecan therapy.  

BKM120 is a P13K inhibitor.  If you want more info, the www.clinicaltrials.gov identifier is NCT01304602.  

Has anyone heard of this clinical trial or this drug?  


Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network